Cargando…

COVID-19 vaccine design: the Janus face of immune enhancement

Previous work on severe acute respiratory syndrome coronavirus (SARS-CoV) vaccines identified cellular immunopathology and antibody-dependent enhancement as potential safety issues. We discuss the implications of these findings for COVID-19 vaccine development and our approach to optimizing for safe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hotez, Peter J., Corry, David B., Bottazzi, Maria Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187801/ https://www.ncbi.nlm.nih.gov/pubmed/32346094 http://dx.doi.org/10.1038/s41577-020-0323-4

Ejemplares similares

COVID-19 vaccines: neutralizing antibodies and the alum advantage
por: Hotez, Peter J., et al.
Publicado: (2020)

The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement
por: Hotez, Peter J., et al.
Publicado: (2020)

Coronavirus vaccine-associated lung immunopathology-what is the significance?
por: Bottazzi, Maria Elena, et al.
Publicado: (2020)

Adapted vaccine strategy: facing the persistent challenges of COVID-19
por: Shang, Lianhan, et al.
Publicado: (2023)

Developing a low-cost and accessible COVID-19 vaccine for global health
por: Hotez, Peter J., et al.
Publicado: (2020)

Will anti-vaccine activism in the USA reverse global goals?
por: Hotez, Peter J.
Publicado: (2022)

Hybrid immunity and strategies for COVID-19 vaccination
por: Hui, David S
Publicado: (2023)

Incentives for COVID-19 vaccination
por: Brewer, Noel T., et al.
Publicado: (2022)

SARS-CoV-2 variants offer a second chance to fix vaccine inequities
por: Hotez, Peter J.
Publicado: (2022)

“The Janus Face” of Thrombocytes in COVID-19
por: SINGH, SUHAIL, et al.
Publicado: (2021)

The elusive goal of COVID-19 vaccine immunity
por: Abu-Raddad, Laith J, et al.
Publicado: (2023)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

Rational use of face masks in the COVID-19 pandemic
por: Feng, Shuo, et al.
Publicado: (2020)

The changing face of medical professionalism and the impact of COVID-19
por: Goddard, Andrew F, et al.
Publicado: (2021)

Face masks help control transmission of COVID-19
por: Clapham, Hannah E, et al.
Publicado: (2021)

COVID-19 vaccines: modes of immune activation and future challenges
por: Teijaro, John R., et al.
Publicado: (2021)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Considerations of hybrid immunity and the future of adolescent COVID-19 vaccination
por: Irving, Stephanie A, et al.
Publicado: (2023)

Africa needs local solutions to face the COVID-19 pandemic
por: Boum, Yap, et al.
Publicado: (2021)

Host Immunity and Inflammation to Pulmonary Helminth Infections
por: Weatherhead, Jill E., et al.
Publicado: (2020)

Human Schistosomiasis Vaccines as Next Generation Control Tools
por: Hotez, Peter J., et al.
Publicado: (2023)

COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges
por: Phelan, Alexandra L
Publicado: (2020)

Physical distancing, face masks, and eye protection for prevention of COVID-19
por: MacIntyre, C Raina, et al.
Publicado: (2020)

COVID-19 and asplenia: a Janus-faced issue
por: Lenti, Marco Vincenzo, et al.
Publicado: (2021)

Global COVID-19 Efforts as the Platform to Achieving the Sustainable Development Goals
por: Mejia, Rojelio, et al.
Publicado: (2020)

XBB.1.5 emerges in the Americas: what it means to the region
por: Hotez, Peter
Publicado: (2023)

Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity
por: Cheng, Kar Keung, et al.
Publicado: (2022)

Public health emergency or opportunity to profit? The two faces of the COVID-19 pandemic
por: van Schalkwyk, May CI, et al.
Publicado: (2021)

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
por: Haberman, Rebecca H, et al.
Publicado: (2022)

Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

Janus-faced probability
por: Rocchi, Paolo
Publicado: (2014)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

The Two Faces of Janus
Publicado: (1993)

The Janus Face of Tumor Microenvironment Targeted by Immunotherapy
por: Buoncervello, Maria, et al.
Publicado: (2019)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

Learning with the COVID-19 pandemic mistakes: Facing the progression of the first cases of Monkeypox in Brazil
por: Boschiero, M.N., et al.
Publicado: (2023)

The “Janus Face” of Platelets in Cancer
por: Catani, Maria Valeria, et al.
Publicado: (2020)

Vaccine Verification in the COVID-19 World
por: Salmon, Daniel A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3j071079d8cjvd0egflphmjfsa